US Stock MarketDetailed Quotes
LAB Standard BioTools
- 1.820
- +0.110+6.43%
Close Nov 27 16:00 ET
- 1.820
- 0.0000.00%
Post 19:13 ET
677.51MMarket Cap-2637P/E (TTM)
1.865High1.715Low1.72MVolume1.720Open1.710Pre Close3.12MTurnover0.73%Turnover RatioLossP/E (Static)372.26MShares3.04052wk High1.39P/B431.65MFloat Cap1.21052wk Low--Dividend TTM237.17MShs Float49.455Historical High--Div YieldTTM8.77%Amplitude0.920Historical Low1.812Avg Price1Lot Size
Standard BioTools Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 77.27%44.97M | 34.48%37.21M | 81.30%45.54M | 8.57%106.34M | 4.32%28.19M | -1.09%25.37M | 47.34%27.67M | -5.23%25.12M | -24.99%97.95M | -29.38%27.02M |
| Operating revenue | 74.19%44.03M | 31.76%36.22M | 83.47%44.62M | 8.57%106.34M | 8.28%29.26M | -1.44%25.28M | 52.49%27.49M | -6.99%24.32M | -23.98%97.95M | -29.11%27.02M |
| Cost of revenue | 52.73%21.71M | 58.54%22.3M | 66.32%21.35M | -8.22%55.89M | -6.45%14.83M | -13.47%14.21M | -1.99%14.06M | -10.02%12.84M | -0.51%60.9M | -12.03%15.85M |
| Gross profit | 108.54%23.26M | 9.60%14.91M | 96.95%24.19M | 36.16%50.45M | 19.61%13.36M | 20.98%11.15M | 207.25%13.6M | 0.36%12.28M | -46.59%37.05M | -44.83%11.17M |
| Operating expense | 65.93%47.56M | 97.67%56.9M | 126.96%62.92M | -18.74%113.49M | 2.22%28.26M | -17.70%28.66M | -32.57%28.78M | -30.24%27.72M | 2.07%139.67M | -12.23%27.65M |
| Selling and administrative expenses | 54.33%34.4M | 66.70%37.67M | 120.44%46.94M | -14.41%87.54M | 5.59%21.35M | -15.37%22.29M | -24.88%22.6M | -31.03%21.3M | 3.44%102.29M | -11.92%20.22M |
| Research and development costs | 106.53%13.16M | 210.83%19.22M | 148.56%15.98M | -30.59%25.95M | -6.95%6.91M | -24.94%6.37M | -50.94%6.18M | -27.48%6.43M | -1.48%37.38M | -13.07%7.43M |
| Operating profit | -38.78%-24.3M | -176.56%-41.99M | -150.83%-38.74M | 38.57%-63.04M | 9.56%-14.91M | 31.63%-17.51M | 60.32%-15.18M | 43.85%-15.44M | -52.12%-102.62M | -46.39%-16.48M |
| Net non-operating interest income expense | 1,059.12%3.94M | 1,721.31%4.44M | 7,086.11%5.17M | -5.45%-4.57M | -338.91%-5.22M | 132.41%340K | 122.98%244K | 106.99%72K | -13.29%-4.33M | -11.01%-1.19M |
| Non-operating interest income | 1,059.12%3.94M | 1,721.31%4.44M | 7,086.11%5.17M | ---- | ---- | --340K | --244K | --72K | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | 5.45%4.57M | ---- | ---- | ---- | ---- | 13.29%4.33M | 11.01%1.19M |
| Other net income (expense) | -71.02%-6.46M | -350.81%-8.12M | 226.72%1.53M | 92.33%-6.6M | 106.16%191K | -8.47%-3.78M | 93.03%-1.8M | 97.50%-1.21M | -1,228.06%-85.98M | -248.61%-3.1M |
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---60.08M | --0 |
| Special income (charges) | -102.51%-7.42M | -276.31%-8.53M | 427.48%3.77M | 0.21%-13.56M | -39.96%-6.48M | -7.10%-3.66M | -655.67%-2.27M | ---1.15M | ---13.59M | ---4.63M |
| -Less：Restructuring and merger&acquisition | 102.51%7.42M | 276.31%8.53M | -427.48%-3.77M | -0.21%13.56M | 39.96%6.48M | 7.10%3.66M | 655.67%2.27M | --1.15M | --13.59M | --4.63M |
| Other non- operating income (expenses) | 932.17%957K | -11.59%412K | -3,686.44%-2.23M | 156.56%6.96M | 336.87%6.67M | -82.54%-115K | 114.39%466K | 99.44%-59K | -261.52%-12.31M | -26.87%1.53M |
| Income before tax | -28.04%-26.82M | -172.79%-45.66M | -93.18%-32.03M | 61.54%-74.2M | 4.03%-19.94M | 30.50%-20.95M | 74.31%-16.74M | 78.43%-16.58M | -203.06%-192.93M | -102.82%-20.78M |
| Income tax | 136.00%118K | -81.73%55K | -51.33%128K | 115.97%452K | -331.43%-162K | 107.01%50K | 118.66%301K | 145.82%263K | 36.02%-2.83M | 108.60%70K |
| Net income | -28.29%-26.94M | -168.30%-45.72M | -90.92%-32.16M | 60.73%-74.66M | 5.13%-19.78M | 28.64%-21M | 73.18%-17.04M | 77.92%-16.84M | -220.91%-190.1M | -121.07%-20.85M |
| Net income continuous Operations | -28.29%-26.94M | -168.30%-45.72M | -90.92%-32.16M | 60.73%-74.66M | 5.13%-19.78M | 28.64%-21M | 73.18%-17.04M | 77.92%-16.84M | -220.91%-190.1M | -121.07%-20.85M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -28.29%-26.94M | -168.30%-45.72M | -90.92%-32.16M | 60.73%-74.66M | 5.13%-19.78M | 28.64%-21M | 73.18%-17.04M | 77.92%-16.84M | -220.91%-190.1M | -121.07%-20.85M |
| Preferred stock dividends | 46.01M | |||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -28.29%-26.94M | -168.30%-45.72M | -364.12%-78.17M | 60.73%-74.66M | 5.13%-19.78M | 28.64%-21M | 73.18%-17.04M | 77.92%-16.84M | -220.91%-190.1M | -121.07%-20.85M |
| Basic earnings per share | 74.07%-0.07 | 45.45%-0.12 | -28.57%-0.27 | 61.32%-0.94 | 3.85%-0.25 | 27.03%-0.27 | 73.17%-0.22 | 78.79%-0.21 | -211.54%-2.43 | -116.67%-0.26 |
| Diluted earnings per share | 74.07%-0.07 | 45.45%-0.12 | -28.57%-0.27 | 61.32%-0.94 | 3.85%-0.25 | 27.03%-0.27 | 73.17%-0.22 | 78.79%-0.21 | -211.54%-2.43 | -116.67%-0.26 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data